EP3366339A1 - Un dispositif d'injection - Google Patents

Un dispositif d'injection Download PDF

Info

Publication number
EP3366339A1
EP3366339A1 EP18161324.1A EP18161324A EP3366339A1 EP 3366339 A1 EP3366339 A1 EP 3366339A1 EP 18161324 A EP18161324 A EP 18161324A EP 3366339 A1 EP3366339 A1 EP 3366339A1
Authority
EP
European Patent Office
Prior art keywords
state
injection device
switch
switches
rotatable surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP18161324.1A
Other languages
German (de)
English (en)
Other versions
EP3366339B1 (fr
Inventor
Robert Veasey
David Aubrey Plumptre
Paul Richard Draper
David Richard Mercer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Priority to EP20153721.4A priority Critical patent/EP3736003A1/fr
Publication of EP3366339A1 publication Critical patent/EP3366339A1/fr
Application granted granted Critical
Publication of EP3366339B1 publication Critical patent/EP3366339B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31566—Means improving security or handling thereof
    • A61M5/31568—Means keeping track of the total dose administered, e.g. since the cartridge was inserted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A61M5/31545—Setting modes for dosing
    • A61M5/31548—Mechanically operated dose setting member
    • A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3327—Measuring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches

Definitions

  • the present disclosure relates to an injection device.
  • Such injection can be performed by using injection devices, which are applied either by medical personnel or by patients themselves.
  • type-1 and type-2 diabetes can be treated by patients themselves by injection of insulin doses, for example once or several times per day.
  • a pre-filled disposable insulin pen can be used as an injection device.
  • a re-usable pen may be used.
  • a re-usable pen allows replacement of an empty medicament cartridge by a new one.
  • Either pen may come with a set of one-way needles that are replaced before each use.
  • the insulin dose to be injected can then for instance be manually selected at the insulin pen by turning a dosage knob and observing the actual dose from a dose window or display of the insulin pen.
  • the dose is then injected by inserting the needle into a suited skin portion and pressing an injection button of the insulin pen.
  • a supplemental device comprising a mating unit for releasably attaching the device to an injection device.
  • This device includes a camera and is configured to perform optical character recognition (OCR) on captured images visible through a dosage window of the injection pen, thereby to determine a dose of medicament that has been dialled into the injection device.
  • OCR optical character recognition
  • a first concept disclosed herein is an injection device, the injection device comprising:
  • the first state may be an open state and the second state may be a closed state.
  • the corrugated rotatable surface may be an inner surface of a cylindrical member.
  • An outer surface of the cylindrical member may be smooth.
  • the injection device may be configured such that, when the rotatable surface is in a rotational position representing an integer dose value, the first and second switches both have either the first state or the second state.
  • An increase or decrease of one integer dose unit in the rotational position of the rotatable surface may cause the state of the first and second switches to change from an initial state to the opposite state and back to the initial state.
  • An increase or decrease of one integer dose unit in the rotational position of the rotatable surface may cause the state of the first and second switches to change from an initial state to the opposite state.
  • An increase or decrease of one integer dose unit in the rotational position of the rotatable surface may cause the state of one of the two switches to change from an initial state to the opposite state while the state of the other of the two switches does not change.
  • the injection device may be configured such that, when the rotatable surface is in a rotational position representing an integer dose value, the first switch has the first state and the second switch has the second state.
  • An increase or decrease of one integer dose unit in the rotational position of the rotatable surface may cause the state of the first and second switches to change from their respective initial states to the opposite states and back to their initial states.
  • An increase or decrease of one integer dose unit in the rotational position of the rotatable surface may cause the state of the first and second switches to change from their respective initial states to the opposite states.
  • the processor arrangement may be configured to determine a direction of rotation of the rotatable surface from the order in which the states of the first and second switches change.
  • An increase or decrease of one integer dose unit in the rotational position of the rotatable surface may cause the state of one of the two switches to change from an initial state to the opposite state and back to the initial state and causes the state of the other of the two switches to change from an initial state to the opposite state.
  • the rotatable surface may be a cylindrical surface and a 360 degree rotation of the cylindrical surface may correspond to 24 integer dose units.
  • the corrugated rotatable surface may have a total of 24 individual corrugations.
  • Figure 1 is an exploded view of an injection device 1, which may for instance represent Sanofi's Solostar (R) insulin injection pen, or Sanofi's Quadrant insulin injection pen.
  • an injection device 1 may for instance represent Sanofi's Solostar (R) insulin injection pen, or Sanofi's Quadrant insulin injection pen.
  • the injection device 1 of Figure 1 is a pre-filled, disposable injection pen that comprises a housing 10 and contains an insulin container 14, to which a needle 15 can be affixed.
  • the needle is protected by an inner needle cap 16 and an outer needle cap 17, which in turn can be covered by a cap 18.
  • An insulin dose to be ejected from injection device 1 can be selected by turning (or “dialling") the dosage knob 12, and the selected dose is then displayed via dosage window 13, for instance in multiples of so-called International Units (IU), also referred to herein as dose units.
  • IU International Units
  • One IU is the biological equivalent of about 45.5 micrograms of pure crystalline insulin (1/22 mg).
  • An example of a selected dose displayed in dosage window 13 may for instance be 30 lUs, as shown in Figure 1 . It should be noted that the selected dose may equally well be displayed differently, for instance by means of an electronic display.
  • Turning the dosage knob 12 may cause a mechanical click sound to provide acoustical feedback to a user.
  • the numbers displayed in dosage window 13 are printed on a sleeve that is contained in housing 10 and mechanically interacts with a piston in insulin container 14.
  • the insulin dose displayed in display window 13 will be ejected from injection device 1.
  • the needle 15 of injection device 1 remains for a certain time in the skin portion after the injection button 11 is pushed, a high percentage of the dose is actually injected into the patient's body. Ejection of the insulin dose also causes a mechanical click sound, which is however different from the sounds produced when using dosage knob 12.
  • Injection device 1 may be used for several injection processes until either insulin container 14 is empty or the expiration date of injection device 1 (e.g. 28 days after the first use) is reached. Furthermore, before using injection device 1 for the first time, it may be necessary to perform a so-called "prime shot” to remove air from insulin container 14 and needle 15, for instance by selecting two units of insulin and pressing injection button 11 while holding injection device 1 with the needle 15 upwards.
  • a so-called "prime shot” to remove air from insulin container 14 and needle 15, for instance by selecting two units of insulin and pressing injection button 11 while holding injection device 1 with the needle 15 upwards.
  • Figure 2 shows an embodiment of a supplemental device 2 attached to injection device 1 of Figure 1 .
  • the supplemental device 2 comprises a housing 20 with a mating unit configured and embrace the housing 10 of the injection device 1 of Figure 1 , so that the supplemental device 2 sits tightly on the housing 10, but is nevertheless removable from the injection device 1, for instance when the injection device 1 is empty and has to be replaced.
  • the supplemental device 2 may be elongate, as shown in Figure 2 , extending over substantially the whole of the housing 10 of the injection device 1. Alternatively, the supplemental device 2 may be shorter, covering only a portion of the housing 10.
  • the supplemental device 2 may have any suitable shape.
  • the supplemental device 2 may have a display unit 21. Information, such as dosage readings, dosage history, instructions, warnings or supplemental device settings may be displayed via the display unit 21.
  • the supplemental device 2 may also have one or more user inputs (not shown). These may comprise buttons or touch sensitive regions on the housing 20 of the device 2. These user inputs may allow a user to turn on/off the supplemental device 2, to trigger actions (for instance to cause establishment of a connection to or a pairing with another device, and/or to trigger transmission of information from supplemental device 2 to another device), or to confirm something.
  • the supplemental device 2 also comprises a processor arrangement (not visible) and a memory (not visible) for storing program instructions.
  • the program and processor arrangement together control operation of the supplemental device 2, including receiving and interpreting signals from switches (described in greater detail below) housed within the device.
  • the injection device 1 to which the supplemental device 2 is to be attached has a corrugated dialling sleeve 119.
  • the corrugations (which may also be referred to as splines, undulations or ridges) are defined by troughs 116 and crests 117.
  • the dialling sleeve 119 is configured to rotate with the dosage knob 12 during dose dialling.
  • the dialling sleeve 119 may be coupled directly to or be integral with the dosage knob 12.
  • dialling sleeve 119 rotates and extends axially outwards from the housing 10.
  • dialling sleeve 119 rotates in the opposite direction and moves back into the housing 10.
  • the supplemental device 2 may house an electromechanical switch arrangement (not shown).
  • the electromechanical switch arrangement may comprise a self-contained unit which is fitted to the supplemental device 2.
  • the electromechanical switch arrangement may for example be housed in a recess in the underside of the supplemental device 2 (the part which contacts the injection device 1).
  • the electromechanical switch arrangement may be secured to the supplemental device 2 by friction or by an interlocking arrangement (not shown), or alternatively by screws, adhesive or the like.
  • the electromechanical switch arrangement is an integral part of the housing 20 of the supplemental device 2.
  • a lower part of the electromechanical switch arrangement is concave in shape and matches the curvature of the injection device 1.
  • the lower part of the electromechanical switch arrangement abuts several of the crests 117 of the corrugated dialling sleeve 119 but the dialling sleeve 119 is free to rotate relative to supplemental device 2.
  • the lower part of the electromechanical switch arrangement may have one or more apertures.
  • Each switch may be an electromechanical micro switch of any suitable type.
  • Each switch has an actuator 400 (also referred to herein as a protrusion, member or limb) and is arranged such that the free end of the actuator passes through an aperture in the electromechanical switch arrangement and protrudes from the housing 20 of the supplemental device 2.
  • An internal spring may bias each switch actuator 400 towards a protruding position, in which the switch actuator abuts and is forced against the surface of the dialling sleeve 119 when the supplemental device 2 is attached, as illustrated in Figure 4 .
  • the switch actuators 400 may be protrusions coupled to an internal member.
  • the internal member may be rotatably mounted.
  • Switch contacts may be disposed on the internal member, or a protruding limb of the internal member.
  • the protrusion which contacts the dialling sleeve surface may also comprise switch contacts on an internal surface such that no intermediary switching members are required.
  • the injection device 1 is configured such that a small portion of the dialling sleeve 119 adjacent the dosage button 12 extends out of the housing 10 of the injection device 1 when no dose has been dialled. This allows the switch actuators 400 to contact the dialling sleeve 119 at all times during operation of the device.
  • Each switch may have electrical contacts supported on an internal surface. These contacts are arranged to be engaged by corresponding electrical contacts on an internal part of each switch actuator 400.
  • the skilled person will be aware of other contact arrangements which may be used as the exact internal structure of the switches is not limiting on the scope of the invention. In any case, the contacts are arranged such that the state of the switch (open or closed) depends on whether the switch actuator 400 is located in a trough 116 or on a crest 117 of the dialling sleeve 119.
  • the supplemental device 2 comprises a processor arrangement.
  • the processor arrangement is configured to control the application of signals to the contacts and to detect when each switch is open or closed.
  • the electromechanical switch arrangement comprises two switches, each switch having an actuator.
  • the two switch actuators are arranged to be spaced circumferentially relative to the dialling sleeve 119 such that each actuator contact the dialling sleeve at a different angular position.
  • the switch actuators may be arranged to be at the same or different longitudinal positions relative to the dialling sleeve.
  • the supplemental device 2 may comprise two separate electromechanical switch arrangements, each comprising a switch and being retained by different part of the supplemental device 2 such that the actuators of the respective switches are spaced circumferentially relative to the dialling sleeve 119. Further description of these embodiments will now be given with reference to Figures 5 to 8 .
  • the user When a user wishes to dial in a dose to the injection device 1, the user grips the dosage knob 12 and rotates it.
  • one full rotation (360 degrees) of the dialling sleeve corresponds to 24 medicament units.
  • the mechanism internal to the injection device 1 is such that only integer units may be dialled into the device. Biasing means internal to the injection device ensure that the dialling sleeve 119 is at equilibrium only when an integer number of dose units are dialled in.
  • the dialling sleeve 119 comprises 24 corrugations.
  • the dialling sleeve 119 has 24 troughs 116 and 24 crests 117.
  • Figures 5a and 5b two embodiments are shown in which the dialling sleeve 119 comprises 24 corrugations.
  • Figure 5a shows a first switch actuator 401 comprising part of the first electromechanical switch and a second switch actuator 402 comprising a part of the second electromechanical switch.
  • This figure also illustrates the first switch actuator dialled up position and dialled down position indicated by the rectangles having a dashed outer boundary and no fill, and the second switch actuator dialled up position and dialled down position indicated by the rectangles having a dashed outer boundary and hashed filling.
  • the positions of the first switch actuator 401 and second switch actuator 402 shown using a solid outer boundary may indicate an initial position of the two switch actuators 401 and 402.
  • the switch actuator positions shown to the left of this initial position illustrate the positional change occurring when one integer dose unit is dialled into the injection device 1.
  • the switch actuator positions shown to the right of this initial position illustrate the positional change occurring when one integer dose unit is dialled out of the injection device 1.
  • both switch actuators 401, 402 are located in a trough 116 of a corrugation in the initial position and after one dose unit has been dialled in or dialled out. For example, starting from the initial position, when one dose unit is dialled in, the switch actuators 401, 402 move left relative to the surface of the dialling sleeve 119.
  • the first switch actuator 401 is the first to ascend the incline to the left, followed by the second switch actuator 402.
  • the switch actuators 401, 402 reach the top of a crest 117, the state of their respective electromechanical switches changes.
  • the switches may have an open state when their respective switch actuator is located in a trough 116 and a closed state when their respective actuator is located on a crest 117, or vice versa.
  • the switch actuators 401, 402 continue to move to the left until they reach the adjacent trough 116. At this point one integer unit of medicament has been dialled into the injection device 1.
  • both switch actuators 401, 402 may equally be located on a crest 117 of a corrugation in the initial position and after one dose unit has been dialled in or dialled out.
  • the troughs 116 and crest 117 of the corrugations may be flat areas linked by straight inclines.
  • the troughs 116 may comprise a flat area while the crest 117 may comprise a smooth curve linking adjacent troughs as shown in Figure 4 .
  • the corrugation may comprise a smooth undulation, such as a sine wave.
  • FIG. 5b a second embodiment is shown in which the dialling sleeve 119 comprises 24 corrugations.
  • the relative separation of the first and second switch actuators 401, 402 is greater than in the embodiment of Figure 5a .
  • the separation of the switch actuators 401, 402 is such that when the dialling sleeve 119 is located in an integer dose unit position, the first and second electromechanical switches have different states.
  • Exemplary initial positions of the first and second switch actuators 401, 402 are illustrated by the rectangles having solid outer boundaries.
  • the positions of the first and second switch actuators after one dose unit has been dialled in or dialled out are illustrated by the rectangles having dashed outer boundaries.
  • the first switch actuator 401 is located on a crest 117 while the second switch actuator 402 is initially located in a trough 116 in every integer unit dose position.
  • the first electromechanical switch may have a closed state while the second electromechanical switch has an open state.
  • the first electromechanical switch is opened before the second electromechanical switch is closed.
  • the second electromechanical switch is closed before the first electromechanical switch is opened.
  • the processor of the supplemental device 2 is able to determine the direction of rotation of the dialling sleeve 119 by monitoring the signals received from the first and second electromechanical switches.
  • the dialling in or out of one unit dose causes both the first and second electromechanical switches to change from their initial state to the opposite state and back again.
  • the processor may use this series of state changes to determine incrementally the number of units which have been dialled into or out of the injection device 1.
  • the dialling sleeve 119 comprises 12 corrugations. It may be advantageous to reduce the number of corrugations of the dialling sleeve 119 in order to reduce the effect of manufacturing tolerances of the dialling sleeve 119 and of the electromechanical switches on the reliability of the switches. Reducing the number of corrugations may also make the dialling sleeve 119 easier and more cost effective to produce.
  • both the first and second switch actuators 401 and 402 are located in a trough 116 of a corrugation, however they may equally both be located on a crest 117 of a corrugation.
  • both the first and second switches change state once, for example from an open state to a closed state.
  • the processor may determine the direction of rotation of the dialling sleeve 119 in the same way as for the embodiment of Figure 5a , i.e. the first electromechanical switch changes state before the second electromechanical switch when a dose unit is dialled in and the second electromechanical switch changes state before the first electromechanical switch when a dose unit is dialled out.
  • the switch actuators are separated by a greater distance than in the embodiment of Figure 6a such that initially the first switch actuator 401 is located in a trough while the second switch actuator 402 is located on a crest.
  • Figure 6b also shows the position of the first and second switch actuators 401 and 402 after one unit has been dialled into the device. In this position the states of the first and second electromechanical switches have been reversed. The position of the first switch actuator 401 after one unit has been dialled out of the device can also be seen. The position of the second switch actuator 402 after one unit has been dialled out is not visible.
  • the separation between the first and second switch actuators is greater than the distance between the centre point of adjacent troughs 116 and crests 117.
  • one of the switches changes state before the other allowing the processor to determine the direction of rotation of the dialling sleeve 119.
  • Having 12 corrugations as opposed to 24 corrugations increases the length of the troughs 116 and crests 117. This increases the margin for error in the separation of the first and second switch actuators 401, 402 which in turn increases the reliability of the system.
  • Figure 7 illustrates an embodiment in which the dialling sleeve 119 comprises 18 corrugations.
  • the separation of the switch actuation members 401, 402 is chosen such that when one unit is dialled in or out of the device, one of the switches changes state once while the other switch changes state twice.
  • the initial positions of the switch actuators 401, 402 are as shown in Figure 7 , with the first switch actuator 401 located in a trough 116 the second switch actuator 402 located on a crest 117, when one unit is dialled into the device the first switch changes from an open state to a closed state while the second switch changes from a closed state to an open state and then back to a closed state.
  • the second switch changes from a closed state to an open state while the first switch changes from an open state to a closed state and back again.
  • the processor must monitor the order in which the first and second switches change state in order to determine the direction of rotation of the dialling sleeve 119.
  • the processor does not need to monitor the order in which the switch state changes occur since each of the first and second electromechanical switches changes state once or twice for each dose unit dialled depending on the direction of rotation.
  • the first and second electromechanical switches when taken together, may represent any one of four states. These are: both switches closed, first switch open and second switch closed, both switches open and first switch closed and second switch open.
  • the order in which these states occur depends on the direction of rotation of the corrugated dialling sleeve.
  • the processor need only know the states of the switches at each integer dose unit position in order to determine a direction of rotation. This may have the advantage of reducing the complexity and power requirements of the processor as the processor does not have to monitor continuously the state changes of the switches.
  • Figure 8 illustrates another embodiment in which the dialling sleeve 119 comprises only 6 corrugations.
  • the first and second switch actuators 401, 402 are arranged such that, taken together, they define four different states.
  • one of the switches changes state once while the other switch remains in the same state.
  • the processor does not need to monitor the order in which the first and second switches change state in order to determine the direction of rotation. The processor only needs to know the start and end states of each of the switches to determine the direction.
  • the processor is also able to incrementally calculate the number of dose units dialled into the injection device 1.
  • the supplemental device 2 is attached to the injection device 1 and activated when zero dose units are dialled in, this encoding method may be used to indicate the currently dialled dose to a user.
  • the supplemental device when attached to the injection device 1, may obscure the display window 13.
  • the processor may determine incrementally a dose dialled into the injection device 1 and display the dialled dose on the display unit 21 of the supplemental device 2.
  • the supplemental device 2 may comprise an optical character recognition (OCR) system configured to read the dialled dose through the display window 13 and to display the result of this reading on the display unit 21.
  • OCR optical character recognition
  • the supplemental device 2 does not obscure the display window 13 when attached to the injection device 1.
  • the display window 13 may be located further down the housing 10 of the injection device 1.
  • three or more electromechanical switches may be housed in the supplemental device 2, each having a switch actuator contacting the dialling sleeve 119. Although only two switches are required to determine a direction of rotation of the dialling sleeve 119, with more than two switches it is possible to achieve a quasi-absolute encoding of the dialling sleeve position and hence the currently dialled dose.
  • electromechanical switches may be replaced by optical, magnetic, resistive or capacitive sensors.
  • dialling sleeve 119 may have optical features, such as black and white regions, which can be detected by optical sensors or conductive and non-conductive regions which may be detected by magnetic, resistive or capacitive sensors.
  • each electromechanical switch may be replaced by a camera.
  • LEDs may also be present to aid in optical recognition.
  • the corrugations may be replaced by parallel black lines having the same separation as adjacent crests of the corrugation.
  • the electromechanical switches may be replaced by contacts which protrude from the housing 20 of the supplemental device 2. These contacts may be configured to engage with conductive and non-conductive regions on the surface of the dialling sleeve 119.
  • the electromechanical switches may be part of an injection device instead of a supplemental device.
  • the corrugated surface is an inner surface. This improves handling as the overall device design is more compact.
  • having an inner corrugated surface leaves the outer surface smooth. Hence, when the outer surface is exposed it can be sealed against moisture and/or dust. Having the inner surface corrugated increases reliability because there is reduced ingression of dust and/or moisture and thus less impact on functionality.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Fuel-Injection Apparatus (AREA)
EP18161324.1A 2013-05-07 2014-05-02 Un dispositif d'injection Active EP3366339B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP20153721.4A EP3736003A1 (fr) 2013-05-07 2014-05-02 Dispositif d'injection

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13166723 2013-05-07
EP14720626.2A EP2994179B1 (fr) 2013-05-07 2014-05-02 Dispositif supplémentaire pour fixation sur un dispositif d'injection
PCT/EP2014/058969 WO2014180744A1 (fr) 2013-05-07 2014-05-02 Dispositif supplémentaire pour fixation a un dispositif d'injection

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
EP14720626.2A Division EP2994179B1 (fr) 2013-05-07 2014-05-02 Dispositif supplémentaire pour fixation sur un dispositif d'injection

Related Child Applications (2)

Application Number Title Priority Date Filing Date
EP20153721.4A Division EP3736003A1 (fr) 2013-05-07 2014-05-02 Dispositif d'injection
EP20153721.4A Division-Into EP3736003A1 (fr) 2013-05-07 2014-05-02 Dispositif d'injection

Publications (2)

Publication Number Publication Date
EP3366339A1 true EP3366339A1 (fr) 2018-08-29
EP3366339B1 EP3366339B1 (fr) 2020-03-04

Family

ID=48463708

Family Applications (3)

Application Number Title Priority Date Filing Date
EP18161324.1A Active EP3366339B1 (fr) 2013-05-07 2014-05-02 Un dispositif d'injection
EP20153721.4A Pending EP3736003A1 (fr) 2013-05-07 2014-05-02 Dispositif d'injection
EP14720626.2A Active EP2994179B1 (fr) 2013-05-07 2014-05-02 Dispositif supplémentaire pour fixation sur un dispositif d'injection

Family Applications After (2)

Application Number Title Priority Date Filing Date
EP20153721.4A Pending EP3736003A1 (fr) 2013-05-07 2014-05-02 Dispositif d'injection
EP14720626.2A Active EP2994179B1 (fr) 2013-05-07 2014-05-02 Dispositif supplémentaire pour fixation sur un dispositif d'injection

Country Status (8)

Country Link
US (4) US10420897B2 (fr)
EP (3) EP3366339B1 (fr)
JP (3) JP6505083B2 (fr)
CN (2) CN105188812B (fr)
DK (2) DK3366339T3 (fr)
HK (1) HK1215404A1 (fr)
TR (1) TR201808342T4 (fr)
WO (1) WO2014180744A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2829497A1 (fr) 2011-03-24 2012-09-27 Sanofi-Aventis Deutschland Gmbh Dispositif et procede de detection d'une action d'actionnement pouvant etre realisee avec un dispositif medical
JP6901975B2 (ja) 2015-06-09 2021-07-14 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 注射デバイスに取り付けられるデータ収集装置
EP3175876A1 (fr) * 2015-12-01 2017-06-07 Carebay Europe Ltd. Dispositif d'administration de médicament avec capacité de rétroaction d'utilisateur
EP3178507A1 (fr) * 2015-12-09 2017-06-14 Carebay Europe Ltd. Dispositif de communication pour transmettre des informations à partir d'un dispositif d'administration de médicament
JP6902546B2 (ja) * 2016-01-06 2021-07-14 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 薬剤送達デバイス
WO2017132577A1 (fr) 2016-01-29 2017-08-03 Companion Medical, Inc. Suivi automatique d'administration de médicament
CN113694314B (zh) 2016-07-15 2023-09-05 伊莱利利公司 用于药物输送装置的剂量检测模块
CN107789706B (zh) * 2016-09-06 2021-12-03 广东东阳光药业有限公司 注射器用数据采集方法、采集结构、注射器及注射系统
EP4374894A2 (fr) 2017-08-18 2024-05-29 Eli Lilly and Company Module de mesure de dosage sur stylo d'injection
CN110958897B (zh) 2017-08-21 2022-08-02 伊莱利利公司 用于药物递送装置的剂量检测模块
EP3672668A1 (fr) * 2017-08-21 2020-07-01 Eli Lilly and Company Dispositif d'administration de médicament doté d'un système de détection
US11529470B2 (en) 2017-08-21 2022-12-20 Eli Lilly And Company Dose detection module for a medication delivery device
US11464459B2 (en) 2017-12-12 2022-10-11 Bigfoot Biomedical, Inc. User interface for diabetes management systems including flash glucose monitor
US11077243B2 (en) 2017-12-12 2021-08-03 Bigfoot Biomedical, Inc. Devices, systems, and methods for estimating active medication from injections
US11083852B2 (en) 2017-12-12 2021-08-10 Bigfoot Biomedical, Inc. Insulin injection assistance systems, methods, and devices
US10987464B2 (en) 2017-12-12 2021-04-27 Bigfoot Biomedical, Inc. Pen cap for insulin injection pens and associated methods and systems
US11090439B2 (en) 2017-12-12 2021-08-17 Bigfoot Biomedical, Inc. Therapy management systems, methods, and devices
US11116899B2 (en) 2017-12-12 2021-09-14 Bigfoot Biomedical, Inc. User interface for diabetes management systems and devices
EA039524B1 (ru) * 2018-05-25 2022-02-07 Эли Лилли Энд Компани Устройство для доставки лекарственного препарата с измерительной системой
US11948671B2 (en) 2019-04-11 2024-04-02 Medtronic Minimed, Inc. Intelligent accessories for medicine dispensing device
KR20210151825A (ko) 2019-04-15 2021-12-14 미쯔비시 케미컬 주식회사 세정액, 세정 방법 및 반도체 웨이퍼의 제조 방법
CN117940179A (zh) * 2021-09-07 2024-04-26 赛诺菲 注射装置和辅助装置

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5509905A (en) * 1992-02-24 1996-04-23 Medimpex Ets Injector display
US20050182360A1 (en) * 2002-06-10 2005-08-18 Julian Yeandel Device and method for dosing a substance
WO2010052275A2 (fr) * 2008-11-06 2010-05-14 Novo Nordisk A/S Dispositif électroniquement assisté d'administration de médicament

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US533575A (en) 1895-02-05 wilkens
DK68789A (da) * 1989-02-14 1990-08-15 Novo Nordisk As Injektionspen
US5226895A (en) 1989-06-05 1993-07-13 Eli Lilly And Company Multiple dose injection pen
GB9007113D0 (en) 1990-03-29 1990-05-30 Sams Bernard Dispensing device
DE59202070D1 (de) 1991-07-24 1995-06-08 Medico Dev Investment Co Injektor.
DK175491D0 (da) 1991-10-18 1991-10-18 Novo Nordisk As Apparat
JPH05184672A (ja) * 1992-01-17 1993-07-27 Tokai Rika Co Ltd 注射器
US5279586A (en) * 1992-02-04 1994-01-18 Becton, Dickinson And Company Reusable medication delivery pen
US5320609A (en) 1992-12-07 1994-06-14 Habley Medical Technology Corporation Automatic pharmaceutical dispensing syringe
US5383865A (en) 1993-03-15 1995-01-24 Eli Lilly And Company Medication dispensing device
ZA941881B (en) 1993-04-02 1995-09-18 Lilly Co Eli Manifold medication injection apparatus and method
JPH06331387A (ja) * 1993-05-26 1994-12-02 Yaskawa Electric Corp 絶対位置検出器
US5582598A (en) 1994-09-19 1996-12-10 Becton Dickinson And Company Medication delivery pen with variable increment dose scale
CA2213682C (fr) 1995-03-07 2009-10-06 Eli Lilly And Company Distributeur recyclable de medicament
US5674204A (en) 1995-09-19 1997-10-07 Becton Dickinson And Company Medication delivery pen cap actuated dose delivery clutch
US5688251A (en) 1995-09-19 1997-11-18 Becton Dickinson And Company Cartridge loading and priming mechanism for a pen injector
JP3437393B2 (ja) * 1996-11-29 2003-08-18 シャープ株式会社 ディスクローディング装置
DE19730999C1 (de) 1997-07-18 1998-12-10 Disetronic Licensing Ag Dosierknopfsicherung an einer Vorrichtung zur dosierten Verabreichung eines injizierbaren Produkts
US5921966A (en) 1997-08-11 1999-07-13 Becton Dickinson And Company Medication delivery pen having an improved clutch assembly
KR100574630B1 (ko) 1998-01-30 2006-04-27 노보 노르디스크 에이/에스 주입 주사기
US5961495A (en) 1998-02-20 1999-10-05 Becton, Dickinson And Company Medication delivery pen having a priming mechanism
US6221053B1 (en) 1998-02-20 2001-04-24 Becton, Dickinson And Company Multi-featured medication delivery pen
US6248095B1 (en) 1998-02-23 2001-06-19 Becton, Dickinson And Company Low-cost medication delivery pen
CA2378325C (fr) 1999-08-05 2008-09-30 Becton, Dickinson And Company Stylo d'administration de produits medicaux
GB0007071D0 (en) 2000-03-24 2000-05-17 Sams Bernard One-way clutch mechanisms and injector devices
US6663602B2 (en) 2000-06-16 2003-12-16 Novo Nordisk A/S Injection device
DE10038936B4 (de) 2000-08-09 2009-02-05 Tecpharma Licensing Ag Vorrichtung zur Dosierung von Substanzen mit kontinuierlicher Sprachausgabe
DE10047637A1 (de) * 2000-09-26 2002-04-25 Disetronic Licensing Ag Vorrichtung zur Verabreichung eines injizierbaren Produkts
US6899699B2 (en) 2001-01-05 2005-05-31 Novo Nordisk A/S Automatic injection device with reset feature
WO2002092153A2 (fr) 2001-05-16 2002-11-21 Eli Lilly And Company Appareil injecteur de medication avec ensemble d'entrainement qui facilite le rearmement
JP2003010327A (ja) * 2001-07-03 2003-01-14 Eisuke Fujimoto 無針注射器
DE10163325B4 (de) * 2001-07-30 2005-07-28 Tecpharma Licensing Ag Verriegelungssperre für eine Verbindung von Gehäuseabschnitten eines Verabreichungsgeräts
DE10163328B4 (de) * 2001-07-30 2005-08-11 Tecpharma Licensing Ag Verabreichungsgerät mit Verdrehsicherung
DE60310233T2 (de) * 2002-07-24 2007-09-13 Deka Products Ltd. Partnership Optischer verschiebungssensor für infusionsgeräte
GB0304823D0 (en) 2003-03-03 2003-04-09 Dca Internat Ltd Improvements in and relating to a pen-type injector
DE10330985A1 (de) * 2003-07-09 2005-02-17 Tecpharma Licensing Ag Vorrichtung zur Verabreichung eines fluiden Produkts mit optischer Abtastung
US20050085776A1 (en) * 2003-10-16 2005-04-21 Edgar Hommann Injection device for administering a fluid product
DE20317377U1 (de) 2003-11-03 2005-03-17 B D Medico S A R L Injektionsgerät
DE602005021331D1 (de) * 2004-03-31 2010-07-01 Lilly Co Eli Injektionsgerät mit einer nadelkassette zur abgabe einer pharmazeutischen flüssigkeit
WO2006045523A1 (fr) 2004-10-21 2006-05-04 Novo Nordisk A/S Systeme de distribution de medicaments presentant un detecteur emettant un signal indicateur d'une quantite d'une dose ejectee d'un medicament
WO2006045524A1 (fr) * 2004-10-21 2006-05-04 Novo Nordisk A/S Dispositif d'injection avec moyen destine a signaler le temps ecoule depuis la derniere ejection
DE102004063648A1 (de) 2004-12-31 2006-07-20 Tecpharma Licensing Ag Injektions- oder Infusionsgerät mit Lebensdauer-Ermittlungseinrichtung
DE102004063664A1 (de) 2004-12-31 2006-07-20 Tecpharma Licensing Ag Echtzeitanzeige für eine Vorrichtung zur dosierten Verabreichung eines Produkts
DK1877119T3 (en) * 2005-01-25 2018-10-15 Novo Nordisk As AN INJECTION DEVICE WITH A DOSAGE END FEEDBACK MECHANISM
US8197449B2 (en) * 2005-05-10 2012-06-12 Novo Nordisk A/S Injection device comprising an optical sensor
EP2060284A1 (fr) 2007-11-13 2009-05-20 F.Hoffmann-La Roche Ag Dispositif d'injection médical avec moyen d'entrée de données et écran pivotant
US8647309B2 (en) 2008-05-02 2014-02-11 Sanofi-Aventis Deutschland Gmbh Medication delivery device
WO2010037828A1 (fr) 2008-10-01 2010-04-08 Novo Nordisk A/S Ensemble médical avec dispositif de surveillance
WO2010088973A1 (fr) * 2009-02-06 2010-08-12 Shl Group Ab Dispositif d'administration de médicament avec détecteur électronique de dose
US9125994B2 (en) * 2009-06-01 2015-09-08 Sanofi—Aventis Deutschland GmbH Drug delivery device with dose dial sleeve rotational stop
IT1394945B1 (it) 2009-07-17 2012-07-27 Cast Meccanica S R L Stampo per lo stampaggio ad iniezione di elementi in materiale plastico, e relativa apparecchiatura di stampaggio
PL215310B1 (pl) * 2009-10-30 2013-11-29 Kappa Medilab Spolka Z Ograniczona Odpowiedzialnoscia Automatyczny aplikator, zwlaszcza do insuliny
TWI633902B (zh) 2010-03-22 2018-09-01 賽諾菲阿凡提斯德意志有限公司 用於判定與醫療裝置有關的資訊之裝置、方法、系統及電腦程式
CN103002839B (zh) 2010-07-16 2015-11-25 伊西康内外科公司 调节体液分配的系统
CA2829497A1 (fr) * 2011-03-24 2012-09-27 Sanofi-Aventis Deutschland Gmbh Dispositif et procede de detection d'une action d'actionnement pouvant etre realisee avec un dispositif medical
WO2013004844A1 (fr) 2011-07-07 2013-01-10 Novo Nordisk A/S Stylo d'injection de médicament doté d'un module de capture et d'affichage de dose auxiliaire
CN103649689B (zh) * 2011-07-15 2016-12-14 赛诺菲-安万特德国有限公司 药物递送装置
US9897980B2 (en) * 2011-07-15 2018-02-20 Sanofi-Aventis Deutschland Gmbh Drug delivery device
EP2919835A1 (fr) * 2012-11-19 2015-09-23 Novo Nordisk A/S Dispositif d'administration de médicament ayant un mécanisme de réglage de dose variable
KR20140090763A (ko) * 2013-01-10 2014-07-18 삼성전자주식회사 약물 주입기의 주사량 측정 장치
CN105764549A (zh) * 2013-11-21 2016-07-13 诺和诺德股份有限公司 具有再同步特征的旋转传感器模块

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5509905A (en) * 1992-02-24 1996-04-23 Medimpex Ets Injector display
US20050182360A1 (en) * 2002-06-10 2005-08-18 Julian Yeandel Device and method for dosing a substance
WO2010052275A2 (fr) * 2008-11-06 2010-05-14 Novo Nordisk A/S Dispositif électroniquement assisté d'administration de médicament

Also Published As

Publication number Publication date
DK2994179T3 (en) 2018-06-18
DK3366339T3 (da) 2020-05-25
JP7398398B2 (ja) 2023-12-14
CN105188812B (zh) 2019-10-08
JP6887455B2 (ja) 2021-06-16
JP2021058712A (ja) 2021-04-15
US20220241514A1 (en) 2022-08-04
CN110585529A (zh) 2019-12-20
EP2994179A1 (fr) 2016-03-16
EP2994179B1 (fr) 2018-03-14
CN110585529B (zh) 2021-12-14
TR201808342T4 (tr) 2018-07-23
US11400231B2 (en) 2022-08-02
HK1215404A1 (zh) 2016-08-26
JP2019076762A (ja) 2019-05-23
US20200023138A1 (en) 2020-01-23
WO2014180744A1 (fr) 2014-11-13
EP3736003A1 (fr) 2020-11-11
JP2016517753A (ja) 2016-06-20
EP3366339B1 (fr) 2020-03-04
JP6505083B2 (ja) 2019-04-24
US20160030680A1 (en) 2016-02-04
US11779709B2 (en) 2023-10-10
US10420897B2 (en) 2019-09-24
CN105188812A (zh) 2015-12-23
US20230405234A1 (en) 2023-12-21

Similar Documents

Publication Publication Date Title
US11779709B2 (en) Supplemental device for attachment to an injection device
EP3463520B1 (fr) Élément de montage pour dispositif accessoire
EP2943236B1 (fr) Système médical d'injection avec capture de dose
AU2018319544B2 (en) Dose detection module for a medication delivery device
KR20200029566A (ko) 감지 시스템을 갖는 약제 전달 장치
EP2958611A1 (fr) Module capteur rotatif à commutateur axial
JP7275353B2 (ja) 注射デバイス
EP3362129B1 (fr) Système de détection de position zéro pour dispositif d'administration de médicament
CN109069756B (zh) 具有剂量捕获的药物输送系统
JP7389650B2 (ja) 内容物終了機構

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AC Divisional application: reference to earlier application

Ref document number: 2994179

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190228

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20190920

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AC Divisional application: reference to earlier application

Ref document number: 2994179

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1239665

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200315

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014062039

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DK

Ref legal event code: T3

Effective date: 20200520

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200604

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20200304

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200604

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200605

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200704

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200729

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1239665

Country of ref document: AT

Kind code of ref document: T

Effective date: 20200304

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014062039

Country of ref document: DE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

26N No opposition filed

Effective date: 20201207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20200531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200502

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200502

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20200531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20200304

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20230309

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DK

Payment date: 20230511

Year of fee payment: 10

Ref country code: DE

Payment date: 20230307

Year of fee payment: 10

Ref country code: CH

Payment date: 20230602

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: TR

Payment date: 20230428

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240314

Year of fee payment: 11